Compounds targeting pmp22 for the treatment of charcot-marie-tooth disease
US-2024360447-A1 · Oct 31, 2024 · US
US8933210B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8933210-B2 |
| Application number | US-201113267414-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 6, 2011 |
| Priority date | Oct 6, 2010 |
| Publication date | Jan 13, 2015 |
| Grant date | Jan 13, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A general methodology to design label-free fluorescent functional nucleic acid sensors using a vacant site approach and an abasic site approach is described. In one example, a method for designing label-free fluorescent functional nucleic acid sensors (e.g., those that include a DNAzyme, aptamer or aptazyme) that have a tunable dynamic range through the introduction of an abasic site (e.g., dSpacer) or a vacant site into the functional nucleic acids. Also provided is a general method for designing label-free fluorescent aptamer sensors based on the regulation of malachite green (MG) fluorescence. A general method for designing label-free fluorescent catalytic and molecular beacons (CAMBs) is also provided. The methods demonstrated here can be used to design many other label-free fluorescent sensors to detect a wide range of analytes. Sensors and methods of using the disclosed sensors are also provided.
Opening claim text (preview).
We claim: 1. A sensor, comprising a catalytic nucleic acid molecule specific for a target agent comprising an enzyme nucleic acid strand and a substrate nucleic acid strand, wherein the enzyme nucleic acid strand comprises a 3′-end and a 5′-end and an active site specific for a target agent, wherein the substrate nucleic acid strand comprises a 3′-end and a 5′-end, wherein the substrate nucleic acid strand comprises nucleotides at the 5′-end of the substrate nucleic acid str…
Chemistry & Metallurgy · mapped topic
Physics · mapped topic
Cross-Sectional Technologies · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.